AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Agilent Technologies Inc. (A)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

141.79

-1.90 (-1.32%)

At close: Feb 11, 2025, 3:59 PM

141.75

-0.03%

After-hours Feb 11, 2025, 08:00 PM EST

undefined% (undefined)

Bid	139.1
Market Cap	40.45B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	4.43
PE Ratio (ttm)	32.01
Forward PE	n/a
Analyst	Hold

Ask	148.64
Volume	894,587
Avg. Volume (20D)	1,732,151
Open	142.23
Previous Close	143.69
Day's Range	141.32 - 144.20
52-Week Range	124.16 - 155.35
Beta	undefined

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorpt...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Nov 18, 1999

Employees 17,400

Stock Exchange NYSE

Ticker Symbol A

Website https://www.agilent.com

Analyst Forecast

According to 14 analyst ratings, the average rating for A stock is "Hold." The 12-month stock price forecast is $150, which is an increase of 5.79% from the latest price.

Buy 42.86%

Hold 50.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Agilent Technologies Inc. is scheduled to release its earnings on Feb 26, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+0.49%

Agilent Technologies shares are trading lower afte... Unlock content with Pro Subscription

5 months ago

+0.16%

Agilent Technologies shares are trading higher after B of A Securities and Evercore ISI Group raised their respective price targets on the stock.

News

2 weeks ago · businesswire.com

Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26. ...

2 weeks ago · businesswire.com

Agilent Automated Workflows at SLAS2025: Connecting with Confidence

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Ex...

3 weeks ago · zacks.com

Agilent Rises 11% in a Year: Should You Buy, Sell or Hold the Stock?

A faces challenges with slowing end-market demand and regulatory hurdles in China, raising growth concerns.

3 weeks ago · seekingalpha.com

Agilent Technologies, Inc. (A) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)

Agilent Technologies, Inc. (NYSE:A ) J.P. Morgan 43rd Annual Healthcare Conference January 14, 2025 12:45 PM ET Company Participants Padraig McDonnell - President and CEO Robert McMahon - Senior VP an...

1 month ago · zacks.com

Agilent (A) Up 1.3% Since Last Earnings Report: Can It Continue?

Agilent (A) reported earnings 30 days ago. What's next for the stock?

1 month ago · zacks.com

Is the Options Market Predicting a Spike in Agilent (A) Stock?

Investors need to pay close attention to Agilent (A) stock based on the movements in the options market lately.

1 month ago · businesswire.com

Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conferen...

1 month ago · https://thefly.com

Agilent investor day calls for margin expansion, says Goldman Sachs

Goldman Sachs keeps a Buy rating and $150 price target on Agilent after the company's investor day presentation. The firm's main takeaways from the event are the forecast for operating margin expansio...

1 month ago · youtube.com

Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics

Padraig McDonnell, Agilent CEO, joins 'Closing Bell Overtime' to talk investors day, its healthcare segment, and more.

2 months ago · businesswire.com

Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IH...

Load More News